BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 22722143)

  • 1. Titanium fixtures for bone-conduction devices and the influence of type 2 diabetes mellitus.
    Horstink L; Faber HT; de Wolf MJ; Dun CA; Cremers CW; Hol MK
    Otol Neurotol; 2012 Aug; 33(6):1013-7. PubMed ID: 22722143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of more than 1,000 implanted percutaneous bone conduction devices: skin reactions and implant survival.
    Dun CA; Faber HT; de Wolf MJ; Mylanus EA; Cremers CW; Hol MK
    Otol Neurotol; 2012 Feb; 33(2):192-8. PubMed ID: 22246385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Removal of titanium implants from the temporal bone: histologic findings.
    van der Pouw CT; Johansson CB; Mylanus EA; Albrektsson T; Cremers CW
    Am J Otol; 1998 Jan; 19(1):46-51. PubMed ID: 9455947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term results with the titanium bone-anchored hearing aid: the U.S. experience.
    Wazen JJ; Caruso M; Tjellstrom A
    Am J Otol; 1998 Nov; 19(6):737-41. PubMed ID: 9831146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anatomical results with titanium implants in the mastoid region.
    Portmann D; Boudard P; Herman D
    Ear Nose Throat J; 1997 Apr; 76(4):231-4, 236. PubMed ID: 9127522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rehabilitation of patients with conductive hearing loss and moderate mental retardation by means of a bone-anchored hearing aid.
    Kunst SJ; Hol MK; Snik AF; Mylanus EA; Cremers CW
    Otol Neurotol; 2006 Aug; 27(5):653-8. PubMed ID: 16788427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone-anchored hearing aid implant location in relation to skin reactions.
    Faber HT; de Wolf MJ; de Rooy JW; Hol MK; Cremers CW; Mylanus EA
    Arch Otolaryngol Head Neck Surg; 2009 Aug; 135(8):742-7. PubMed ID: 19687391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone-anchored hearing aid surgery in older adults: implant loss and skin reactions.
    de Wolf MJ; Hol MK; Mylanus EA; Cremers CW
    Ann Otol Rhinol Laryngol; 2009 Jul; 118(7):525-31. PubMed ID: 19708493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of factors predicting the success of the bone conduction device headband trial in patients with single-sided deafness.
    Faber HT; Kievit H; de Wolf MJ; Cremers CW; Snik AF; Hol MK
    Arch Otolaryngol Head Neck Surg; 2012 Dec; 138(12):1129-35. PubMed ID: 23247232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osseointegration timing for Baha system loading.
    Wazen JJ; Gupta R; Ghossaini S; Spitzer J; Farrugia M; Tjellstrom A
    Laryngoscope; 2007 May; 117(5):794-6. PubMed ID: 17473670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implant survival rate in bone-anchored hearing aid users: long-term results.
    Wallberg E; Granström G; Tjellström A; Stalfors J
    J Laryngol Otol; 2011 Nov; 125(11):1131-5. PubMed ID: 21774847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone-anchored hearing aid (Baha) in patients with Treacher Collins syndrome: tips and pitfalls.
    Marsella P; Scorpecci A; Pacifico C; Tieri L
    Int J Pediatr Otorhinolaryngol; 2011 Oct; 75(10):1308-12. PubMed ID: 21839526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of hearing loss among Saudi type 2 diabetic patients.
    Bamanie AH; Al-Noury KI
    Saudi Med J; 2011 Mar; 32(3):271-4. PubMed ID: 21384063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of osteoporotic status on the survival of titanium dental implants.
    Holahan CM; Koka S; Kennel KA; Weaver AL; Assad DA; Regennitter FJ; Kademani D
    Int J Oral Maxillofac Implants; 2008; 23(5):905-10. PubMed ID: 19014161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of local infiltration of insulin around titanium implants in diabetic rats.
    Wang B; Song Y; Wang F; Li D; Zhang H; Ma A; Huang N
    Br J Oral Maxillofac Surg; 2011 Apr; 49(3):225-9. PubMed ID: 20400213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arkansas BAHA experience: transcalvarial fixture placement using osseointegration surgical hardware.
    Lee CE; Christensen L; Richter GT; Dornhoffer JL
    Otol Neurotol; 2011 Apr; 32(3):444-7. PubMed ID: 21307809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of 2 implantable bone conduction devices in patients with single-sided deafness using a daily alternating method.
    Desmet JB; Wouters K; De Bodt M; Van de Heyning P
    Otol Neurotol; 2012 Aug; 33(6):1018-26. PubMed ID: 22772008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability of osseointegrated bone conduction systems in children: a pilot study.
    Marsella P; Scorpecci A; D'Eredità R; Della Volpe A; Malerba P
    Otol Neurotol; 2012 Jul; 33(5):797-803. PubMed ID: 22643446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term Compliance and Satisfaction With Percutaneous Bone Conduction Devices in Patients With Congenital Unilateral Conductive Hearing Loss.
    Nelissen RC; Mylanus EA; Cremers CW; Hol MK; Snik AF
    Otol Neurotol; 2015 Jun; 36(5):826-33. PubMed ID: 25853613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.